Glatiramer acetate
Signals from filings dated June 2026 – June 2026 · Last checked 7 Nov 2026
Supply outlook
↑ GROWINGIn the filings we track: 1 plant adding this molecule, 0 exit signals, 0 intermediate projects.
↑ Coming in1 plant+1.2 t/yr, where filed in tonnes
↓ Leaving0no drops or surrenders found
⇄ Own intermediates0no KSM projects found
Furthest stageHearingno clearance granted yet
Signals
↑ NEW PLANT
+1.2 t/yrAmneal Biopharma Synthesis Pvt. Ltd.
Survey No. 259, Kochariya, Bavla, Ahmedabad, Gujarat
- ✓ Terms of reference
- ✓ Public hearing · 19 Jun 2026
- Next: clearance
- Consent to operate
- DMF / CEP
New peptide API unit. Same filing: an unnamed peptide molecule at 12 t/yr and R&D products at 1.2 t/yr; 14.4 t/yr in total. Public hearing held 19 Jun 2026. Source: Public hearing record, GPCB
Who makes Glatiramer acetate today: 9 listings
Current manufacturers with US DMF and CEP status, plant addresses and contacts.
| Manufacturer | Country | US DMF | CEP | Contact |
|---|---|---|---|---|
| Dr Reddy's Laboratories Ltd | India | ✓ | — | In database |
| Corden Pharma Brussels | Belgium | ✓ | — | In database |
| Plantex Ltd | Israel | — | — | In database |
| + 6 more listings in api-fdf.com → | ||||
Three examples from the api-fdf.com database, refreshed weekly. Plant addresses and contacts are shown in the database.
Follow Glatiramer acetate
Get an email when a new filing adds, cuts or moves this molecule to the next stage.